Tang Shan, Bai Li, Gao Yuan, Hou Wei, Song Wenyan, Liu Hui, Hu Zhongjie, Duan Zhongping, Zhang Liaoyun, Zheng Sujun
Beijing Youan Hospital, Capital Medical University, Beijing, China.
The First Hospital of Shanxi Medical University, Taiyuan, China.
Front Genet. 2022 Apr 8;13:836431. doi: 10.3389/fgene.2022.836431. eCollection 2022.
Type 3 hereditary hemochromatosis (HH) is a rare form of HH characterized by genetic mutation in the gene. Clinical features reported in patients with type 3 HH include abnormal liver function, liver fibrosis, cirrhosis, diabetes, hypogonadism, cardiomyopathy, and skin pigmentation. Since its original description in 2000, 33 pathogenic mutations associated with HH have been described until now. Here, we first reported a Chinese pedigree of -related hemochromatosis with a novel compound heterozygous mutation c.1288G > A (p.G430R)/c.960T > A (p.Y320X). Interestingly, different phenotypes were reported although the proband and his sister shared the same gene mutation. This inconsistency between genotypes and phenotypes indicates multifactorial etiology contributing to the development of HH. Our report broadens the mutation spectrum of the gene associated with HH.
3型遗传性血色素沉着症(HH)是HH的一种罕见形式,其特征是该基因发生基因突变。3型HH患者报告的临床特征包括肝功能异常、肝纤维化、肝硬化、糖尿病、性腺功能减退、心肌病和皮肤色素沉着。自2000年首次描述以来,迄今为止已描述了33种与HH相关的致病突变。在此,我们首次报告了一个与相关血色素沉着症的中国家系,该家系具有一种新的复合杂合突变c.1288G>A(p.G430R)/c.960T>A(p.Y320X)。有趣的是,尽管先证者和他的妹妹共享相同的基因突变,但报告了不同的表型。基因型和表型之间的这种不一致表明多因素病因导致HH的发生。我们的报告拓宽了与HH相关的该基因突变谱。